Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies-Reference-Cited by-同舟云学术

Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

Published:2023-02-01 Issue:1 Volume:39 Page:55-62
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Weinreb Robert N.¹,Bacharach Jason²,Brubaker Jacob W.³,Medeiros Felipe A.⁴,Bejanian Marina⁵,Bernstein Paula⁵⁶,Robinson Michael R.⁵

Affiliation:

1. Hamilton Glaucoma Center and Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, California, USA.

2. North Bay Eye Associates, Petaluma, California, USA.

3. Sacramento Eye Consultants, Sacramento, California, USA.

4. Duke Eye Center, Durham, North Carolina, USA.

5. Allergan, an AbbVie company, Irvine, California, USA.

6. Bernstein Biostatistics Consulting, LLC, Laguna Niguel, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2022.0137

Reference21 articles.

1. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)

2. Biodegradable Implants for Sustained Drug Release in the Eye

3. Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial

4. 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

5. Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Eye Care to Hair Growth: Bimatoprost;Pharmaceuticals;2024-04-27

2. Cystoid macular edema occurring after intracameral bimatoprost implantation;European Journal of Ophthalmology;2024-04-15

3. Lipid mediators in glaucoma: Unraveling their diverse roles and untapped therapeutic potential;Prostaglandins & Other Lipid Mediators;2024-04

4. Real-World Analysis of the Efficacy of Bimatoprost Sustained-Release Glaucoma Implant Where American Indians Comprise the Largest Minority Population;Clinical Ophthalmology;2024-03

5. Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review;Current Opinion in Pharmacology;2024-02